| Linette Yadira Rosario Tejeda, MD | |
|
2979 Main St, Bridgeport, CT 06606-4284 | |
| (203) 382-2345 | |
| Not Available |
| Full Name | Linette Yadira Rosario Tejeda |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 2979 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891082079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 053538 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Healthcare At Home | Bloomfield, CT | Hospice |
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others.
SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.
› Verified 3 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others.
SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.
› Verified 3 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others.
SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linette Yadira Rosario Tejeda, MD 1276 Fulton Ave Fl 4, Bronx, NY 10456-3402 Ph: (718) 901-8294 | Linette Yadira Rosario Tejeda, MD 2979 Main St, Bridgeport, CT 06606-4284 Ph: (203) 382-2345 |
News Archive
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others.
SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.
› Verified 3 days ago
Dr. Frank Raymond Scifo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-5986 Fax: 203-576-6020 | |
Dr. John P Iannarone, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 4600 Main St, Bridgeport, CT 06606 Phone: 203-371-4445 | |
Pierre Hubert Estime, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Albion St, Bridgeport, CT 06605 Phone: 203-330-6000 Fax: 203-330-6007 | |
Laura Belland, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 | |
Dr. Maria Mikolaenko, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2979 Main St, Bridgeport, CT 06606 Phone: 203-382-2345 Fax: 203-366-0868 | |
Dennis Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1381 Reservoir Ave, Bridgeport, CT 06606 Phone: 203-371-5197 Fax: 203-371-6118 | |
David F Altamirano, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6000 |